Comparing Lomotil vs Viberzi
| Lomotil (atropine / diphenoxylate) | Viberzi (eluxadoline) |
|
|---|
| Lomotil (atropine / diphenoxylate) | Viberzi (eluxadoline) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Diarrhea. Lomotil may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Irritable Bowel Syndrome with Diarrhea, Irritable Bowel Syndrome, Diarrhea. Viberzi may also be used for purposes not listed in this medication guide. |
Related suggestions Popular comparisons
|
|||||||
| More about Lomotil (atropine / diphenoxylate) | More about Viberzi (eluxadoline) | ||||||||
| Ratings & Reviews | |||||||||
|
Lomotil has an average rating of 8.1 out of 10 from a total of 50 ratings on Drugs.com. 74% of reviewers reported a positive effect, while 14% reported a negative effect. |
Viberzi has an average rating of 6.7 out of 10 from a total of 217 ratings on Drugs.com. 57% of reviewers reported a positive effect, while 25% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Lomotil side effects |
View all Viberzi side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
View all Lomotil prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms | |||||||||
|
N/A |
||||||||
| Brand Names | |||||||||
| Other atropine / diphenoxylate brands include: Logen, Lomanate |
N/A |
||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
14 hours |
6 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Some potential for abuse
Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4. |
Some potential for abuse
Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
||||||||
| Pregnancy Category | |||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 317 drugs are known to interact with Lomotil:
|
A total of 214 drugs are known to interact with Viberzi:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
|
||||||||
| Disease Interactions | |||||||||
|
|||||||||
| First Approval Date | |||||||||
|
September 15, 1960 |
May 27, 2015 |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.